The newly discovered omicron variant has been labeled a "variant of concern" by the World Health Organization—but how serious will it ultimately be for public health? That will depend, experts say, on the still-unknown answers to these three key questions.
Newly released data from the Epic Health Research Network has shed new light on the demographics of so-called "breakthrough" coronavirus infections in vaccinated people. Explore how different generations are being afflicted by breakthrough infections, hospitalizations, and deaths on our interactive chart.
Some infectious disease experts have said new antiviral Covid-19 drugs could be a "game-changer" in the fight against Covid-19, especially in the face of emerging coronavirus variants such as omicron. But other experts worry it will be difficult to test and treat patients quickly enough for the drugs to be effective.
New safety data published last week in JAMA Neurology showed that 41% of Aduhelm patients experienced either bleeding or swelling in the brain—and while these symptoms have been known side effects, the recent death of an Aduhelm patient is adding to the drug's continued controversy.
As Covid-19 cases in children continue to rise, several health experts underscore the need for pediatric vaccinations—not only to protect children, but also to prevent the development of more dangerous coronavirus variants.
The Biden administration has allocated $1.5 billion in scholarships and loan repayment assistance for students and health care workers in underserved communities, in today's bite-sized hospital and health industry news from the District of Columbia and Missouri.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.